Carlos Chocarro-Wrona
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Carlos Chocarro-Wrona has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
- Juan Antonio Marchal
Biopathology and Regenerative Medicine Institute (IBIMER), Centre for Biomedical Research (CIBM), University of Granada, Granada, Spain
3 shared publications - Elena López-Ruiz
Universidad de Granada
2 shared publications - Juan de Vicente
F2N2Lab, Magnetic Soft Matter Group, Department of Applied Physics, Faculty of Sciences, University of Granada, C/Fuentenueva s/n, Granada 18071, Spain
2 shared publications - Patricia Gálvez-Martín
R&D Human Health, Bioibérica S.A.U. Barcelona 08950 Spain
2 shared publications - Albane Carré
LVTS, 46 Rue Henri Huchard, Paris, Île-de-France, 75877, FRANCE
1 shared publication - Alizée Mosnier
3d.FAB, CNRS UMR 5246, ICBMS (Institute of Molecular and Supramolecular Chemistry and Biochemistry), Université Lyon 1, Villeurbanne, France
1 shared publication
Latest Publications
- Open Access
- 25 July 2025
- Published by Wiley in Advanced Healthcare Materials
- Vol. 15 (5) , e00702
A Novel Sprayable Fibrinogen/Glycosaminoglycans/Collagen‐Based Bioink for Skin Wound Healing Applied by a Handheld Dual‐Head Airbrush
In the last years, different biofabrication methods have gained special attention for the production of skin substitutes that overcome the limitations of conventional skin grafting. Skin sprays represent a promising technology for treating cutaneous wounds as they can deliver both cells and biomaterials to the wound bed in a fast and easy approach, covering extensive wound surfaces. The aim of this study is to develop a novel bioink based on fibrinogen supplemented with a glycosaminoglycans (GAGs)/collagen (Col)‐based matrix, containing hyaluronic acid, dermatan sulfate, chondroitin sulfate, and Col, in combination with an innovative dual‐head airbrush‐based spraying device. The fibrinogen/GAGs/Col‐based bioink is loaded with human mesenchymal stromal cells or human dermal fibroblasts, and its physicochemical and mechanical properties are analyzed, as well as cell viability, metabolic activity, and in vitro wound healing. Finally, its skin wound healing properties are studied in an in vivo excisional wound healing murine model. The bioink forms hydrogels with satisfactory physicochemical, mechanical, and biological properties, capable of promoting wound healing and tissue regeneration in vivo with outcomes comparable to those of autografts. The novel spray system and bioink show the potential to serve as a therapeutic tool for the clinical treatment of cutaneous wounds.
- 25 July 2025
- Published by Wiley in Advanced Healthcare Materials
- Vol. 15 (5) , e00702
Open AccessA Novel Sprayable Fibrinogen/Glycosaminoglycans/Collagen‐Based Bioink for Skin Wound Healing Applied by a Handheld Dual‐Head Airbrush
In the last years, different biofabrication methods have gained special attention for the production of skin substitutes that overcome the limitations of conventional skin grafting. Skin sprays represent a promising technology for treating cutaneous wounds as they can deliver both cells and biomaterials to the wound bed in a fast and easy approach, covering extensive wound surfaces. The aim of this study is to develop a novel bioink based on fibrinogen supplemented with a glycosaminoglycans (GAGs)/collagen (Col)‐based matrix, containing hyaluronic acid, dermatan sulfate, chondroitin sulfate, and Col, in combination with an innovative dual‐head airbrush‐based spraying device. The fibrinogen/GAGs/Col‐based bioink is loaded with human mesenchymal stromal cells or human dermal fibroblasts, and its physicochemical and mechanical properties are analyzed, as well as cell viability, metabolic activity, and in vitro wound healing. Finally, its skin wound healing properties are studied in an in vivo excisional wound healing murine model. The bioink forms hydrogels with satisfactory physicochemical, mechanical, and biological properties, capable of promoting wound healing and tissue regeneration in vivo with outcomes comparable to those of autografts. The novel spray system and bioink show the potential to serve as a therapeutic tool for the clinical treatment of cutaneous wounds.
- Open Access
- 2 July 2024
- Published by Elsevier in Bioprinting
- Vol. 41
Unlocking the potential of bio-inspired bioinks: A collective breakthrough in mammalian tissue bioprinting
- 2 July 2024
- Published by Elsevier in Bioprinting
- Vol. 41
Open AccessUnlocking the potential of bio-inspired bioinks: A collective breakthrough in mammalian tissue bioprinting
- 10 May 2021
- Published by IOP Publishing in Smart Materials and Structures
- Vol. 30 (6) , 065015
Living magnetorheological composites: from the synthesis to the in vitro characterization
A new type of magnetorheological (MR) material is reported that brings together conventional MR composites (MRCs) and biomaterials. Living MRCs based on carbonyl iron microparticles (CIPs) as magnetoactive filler, sodium alginate as elastomer and cells as biological components were prepared and characterized. The effect of CIPs concentration in isotropic alginate composites was examined by using thermogravimetric analysis, infrared spectroscopy, swelling and degradation tests in culture medium (Dulbecco’s Modified Eagle’s Medium, DMEM). To self-assemble the CIPs within the polymer matrix, the cross-linking process took place under an external magnetic field (24 mT). The cytotoxicity experiments were performed with human mesenchymal stem cells and human fibroblasts loaded inside of the hydrogel. It was demonstrated that the living MRCs supported cell survival and proliferation. The rheological response of the MRCs was evaluated in dynamic oscillatory tests in the absence and presence of magnetic fields. The viscoelastic response of the living MRCs improved when a magnetic field was applied. This work demonstrates the possibility to use CIPs in the fabrication of living composites with MR response. Results could be of interest in smart biomedical applications.
- 10 May 2021
- Published by IOP Publishing in Smart Materials and Structures
- Vol. 30 (6) , 065015
Living magnetorheological composites: from the synthesis to the in vitro characterization
A new type of magnetorheological (MR) material is reported that brings together conventional MR composites (MRCs) and biomaterials. Living MRCs based on carbonyl iron microparticles (CIPs) as magnetoactive filler, sodium alginate as elastomer and cells as biological components were prepared and characterized. The effect of CIPs concentration in isotropic alginate composites was examined by using thermogravimetric analysis, infrared spectroscopy, swelling and degradation tests in culture medium (Dulbecco’s Modified Eagle’s Medium, DMEM). To self-assemble the CIPs within the polymer matrix, the cross-linking process took place under an external magnetic field (24 mT). The cytotoxicity experiments were performed with human mesenchymal stem cells and human fibroblasts loaded inside of the hydrogel. It was demonstrated that the living MRCs supported cell survival and proliferation. The rheological response of the MRCs was evaluated in dynamic oscillatory tests in the absence and presence of magnetic fields. The viscoelastic response of the living MRCs improved when a magnetic field was applied. This work demonstrates the possibility to use CIPs in the fabrication of living composites with MR response. Results could be of interest in smart biomedical applications.
- 6 December 2018
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 33 (3) , 484-496
Therapeutic strategies for skin regeneration based on biomedical substitutes
Regenerative medicine and tissue engineering (TE) have experienced significant advances in the development of in vitro engineered skin substitutes, either for replacement of lost tissue in skin injuries or for the generation of in vitro human skin models to research. However, currently available skin substitutes present different limitations such as expensive costs, abnormal skin microstructure and engraftment failure. Given these limitations, new technologies, based on advanced therapies and regenerative medicine, have been applied to develop skin substitutes with several pharmaceutical applications that include injectable cell suspensions, cell‐spray devices, sheets or 3Dscaffolds for skin tissue regeneration and others. Clinical practice for skin injuries has evolved to incorporate these innovative applications to facilitate wound healing, improve the barrier function of the skin, prevent infections, manage pain and even to ameliorate long‐term aesthetic results. In this article, we review current commercially available skin substitutes for clinical use, as well as the latest advances in biomedical and pharmaceutical applications used to design advanced therapies and medical products for wound healing and skin regeneration. We highlight the current progress in clinical trials for wound healing as well as the new technologies that are being developed and hold the potential to generate skin substitutes such as 3D bioprinting‐based strategies.
- 6 December 2018
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 33 (3) , 484-496
Therapeutic strategies for skin regeneration based on biomedical substitutes
Regenerative medicine and tissue engineering (TE) have experienced significant advances in the development of in vitro engineered skin substitutes, either for replacement of lost tissue in skin injuries or for the generation of in vitro human skin models to research. However, currently available skin substitutes present different limitations such as expensive costs, abnormal skin microstructure and engraftment failure. Given these limitations, new technologies, based on advanced therapies and regenerative medicine, have been applied to develop skin substitutes with several pharmaceutical applications that include injectable cell suspensions, cell‐spray devices, sheets or 3Dscaffolds for skin tissue regeneration and others. Clinical practice for skin injuries has evolved to incorporate these innovative applications to facilitate wound healing, improve the barrier function of the skin, prevent infections, manage pain and even to ameliorate long‐term aesthetic results. In this article, we review current commercially available skin substitutes for clinical use, as well as the latest advances in biomedical and pharmaceutical applications used to design advanced therapies and medical products for wound healing and skin regeneration. We highlight the current progress in clinical trials for wound healing as well as the new technologies that are being developed and hold the potential to generate skin substitutes such as 3D bioprinting‐based strategies.